Janus kinase (JAK) inhibitors are associated with an increased risk for lung cancer but not overall cancer among older patients in the United States with rheumatoid arthritis (RA), according to study ...

It was the first partially selective TACE inhibitor to reach phase II clinical trials for the treatment of RA and was tested in the preclinical setting for inflammatory bowel disease. BMS has ...

Perspective from Devin Weidman, MSN, APRN-C TNF inhibitor use demonstrates no negative ... The study included 1,981 patients with RA split into three different groups — those with early-stage ...

Most effective RA treatments cause neutropenia ... although the company's ambition is the entire $11 billion TNF-α inhibitor market. Also, Rigel is planning a study to separate out R788's ...

Humira is a type of immunosuppressant known as a tumor necrosis factor (TNF) inhibitor. It’s prescribed to treat autoimmune conditions. TNF is a protein that plays a key role in inflammation.